This study also demonstrated that SUR1-TRPM4-expressing astrocytes within human MS lesions also co-expressed other pathogenic molecules, including NOS2, BAFF, and CCL2, similar to the murine findings discussed above (Section 3.7.1). This evidence concerns the gene ABCC8 and myeloid sarcoma.